Kamiyama et al., 1995 - Google Patents
Monamidocin, a Novel Fibrinogen Receptor Antagonist II. Biological Activity and Structure-activity RelationshipsKamiyama et al., 1995
View PDF- Document ID
- 8308147960903823173
- Author
- Kamiyama T
- Satoh T
- Umino T
- Katoh H
- Uemura F
- Nakamura Y
- Yokose K
- Publication year
- Publication venue
- The Journal of Antibiotics
External Links
Snippet
Monamidocin, a fibrinogen receptor binding inhibitor produced by Streptomyces sp. NR0637, inhibits the binding of fibrinogen to its receptor with an IC50 of 0.21/jm. It also inhibits ADP-, collagen-and thrombin-induced aggregation of humanplatelet with IC5Osof …
- 230000000694 effects 0 title description 12
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4565653A (en) | Acyltripeptide immunostimulants | |
US4715994A (en) | Novel antibacterial agents and potentiators of carbapenem antibiotics | |
Abell et al. | Synthesis of a cis-conformationally restricted peptide bond isostere and its application to the inhibition of the HIV-1 protease | |
SK64993A3 (en) | Hydroxamic acid derivatives, method of their preparation and medicaments with their content | |
HU180529B (en) | Process for producing cysteinyl-l-proline | |
NZ200164A (en) | N-substituted amido-amino acids and pharmaceutical compositions | |
US5099063A (en) | Certain phosphinic acid derivatives having antibacterial activity | |
JPH05170792A (en) | Phosphono/biaryl-substituted dipeptide derivative | |
JPH10512257A (en) | Substituted oxazolidine calpain and / or cathepsin B inhibitors | |
HU200191B (en) | Process for production of new dipeptides | |
HU204539B (en) | Process for producing oligopeptides containing cyclic proline-analogue amino-acids and pharmaceutical compositions contaiing them as active components | |
WO1996033968A1 (en) | Highly water-soluble metalloproteinase inhibitor | |
JP2000510447A (en) | 6-Substituted amino-4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as cysteine protease inhibitors | |
KR20150065718A (en) | Indolines | |
Kamiyama et al. | Monamidocin, a Novel Fibrinogen Receptor Antagonist II. Biological Activity and Structure-activity Relationships | |
IE45095B1 (en) | Dipeptide derivatives | |
US4490386A (en) | Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof | |
JPS61100564A (en) | Peptide-substituted heterocyclic immunostimulants | |
JP4381531B2 (en) | Glycopeptide derivative | |
CZ322092A3 (en) | N-(alpha-substituted pyridinyl)carbonyl dipeptides, process of their preparation and pharmaceutical compositions based thereon | |
CA2855415A1 (en) | Phenylalanine derivatives | |
US4767743A (en) | Peptide immunostimulants | |
FI83523B (en) | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA DERIVAT AV BICYKLISKA AMINOSYROR. | |
EP4003969A1 (en) | Selective bcrp/abcg2 transporter inhibitors as agents to abolish resistance to anti-cancer agents | |
JP4659843B2 (en) | Novel derivatives of phosphinicaminoacids, process for their production and pharmaceutical compositions containing them |